№ lp_2_1_03851
File format: docx Character count: 13001 File size: 5790 KB
Clinical case report describing the presentation, diagnostic evaluation, histopathological findings, and immunosuppressive management of mixed essential cryoglobulinemia with renal involvement in a 52-year-old male patient treated in a tertiary nephrology center in Pakistan.
Type of document: Case report
Journal: PJKD
Year: 2024
Volume and issue: 8(1)
DOI: Not specified
Received: April 26, 2023
Accepted: October 27, 2023
Authors: Sajid Islam Bhatti; Tajammul Waqar; Shafique Younus; Sidra German
Corresponding author: Sajid Islam Bhatti
Author affiliation: Department of Nephrology, Sindh Institute of Urology and Transplantation (SIUT), Karachi, Pakistan
Country: Pakistan
Clinical setting: Sindh Institute of Urology and Transplantation (SIUT), Karachi
Subject area: Nephrology
Keywords: Mixed essential cryoglobulinemia; mesangiocapillary glomerulonephritis; HCV; purpura; vasculitis
Patient profile: 52-year-old male
Study focus: Renal involvement in mixed essential cryoglobulinemia
Diagnostic methods: Renal biopsy; immunofluorescence; serology; complement levels; imaging studies
Treatment: Prednisolone; mycophenolate mofetil; cyclophosphamide
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Hepatitis B vaccine Renal Patient Group Direction (PGD)
Year: 2025
Region: England
Subject: Hepatitis B vaccination for renal patients
Document Type: Patient Group Direction (PGD)
Authorising Organisation: UK Health Security Agency (UKHSA)
Target Audience: Registered healthcare professionals
Period of Validity: 28 February 2025 - 28 February 2028
Approval Date: 28 February 2025
Amendment Date: 21 February 2025
Canberra Health Services Procedure Continuous Renal Replacement Therapy in Intensive Care
Year: 2023
Region / City: Canberra
Topic: Continuous Renal Replacement Therapy
Document Type: Procedure
Organization: Canberra Health Services
Author: Not specified
Target Audience: Medical Officers, Nurses, Midwives, Physiotherapists, Students under direct supervision
Period of Validity: Not specified
Approval Date: Not specified
Amendment Date: Not specified
Protocol for the Examination of Resection Specimens from Patients with Renal Cell Carcinoma
Version: 4.2.1.0
Protocol Posting Date: June 2025
CAP Laboratory Accreditation Program Protocol Required Use Date: March 2026
Year: 2025
Region / City: Not specified
Subject: Renal cell carcinoma, nephrectomy, tumor classification
Document Type: Protocol
Institution: CAP (College of American Pathologists)
Author: Paari Murugan, MD, FCAP*, Robert W. Allan, MD, FCAP*, Lara R. Harik, MD, FCAP*
Target Audience: Pathologists, medical professionals involved in cancer diagnostics
Effective Period: March 2026 onward
Approval Date: June 2025
Revision Date: Not specified
RENAL MEDICINE ST4 ENTRY CRITERIA
Note: Qualifications
Radiological investigation in acute renal colic
Year: 2010
Region / City: Not specified
Theme: Radiology, Acute Renal Colic, Imaging, Diagnostic Yield
Document Type: Audit
Institution: Not specified
Target Audience: Medical professionals, Radiologists, Urologists
Period of Effect: Not specified
Approval Date: 19 February 2010
Date of Last Review: 18 February 2021
Renal Medicine ST4 Entry Criteria
Note: Year
Context: Criteria for entry into the ST4 Renal Medicine program in the UK, outlining essential qualifications, eligibility requirements, career progression, and clinical experience.
Supplemental Tables 1–5. Analyses of Factors Associated with Composite Complication Endpoint, Diagnostic Yield, and Therapeutic Consequences of in-ICU Transvenous Renal Biopsies
Number of patients: 80
Setting: Intensive care unit
Procedure: Transvenous renal biopsy
Study design: Observational analytical study
Statistical methods: Student’s t-test; Wilcoxon’s rank test; χ2 test; logistic regression with backward-stepwise variable elimination
Outcomes assessed: Composite complication endpoint; acute tubular necrosis diagnosis; diagnostic yield; in-ICU mortality; therapeutic consequences
Variables analyzed: Demographic characteristics; clinical scores (SOFA, SAPS II); laboratory parameters; anticoagulation and antiplatelet therapy; bleeding-risk factors; vasopressor use; mechanical ventilation; extracorporeal membrane oxygenation
Time comparison: TVRB performed before 2012 vs after 2012; biopsy after 2015
Therapeutic interventions evaluated: Corticosteroids; cyclophosphamide; plasmapheresis; intravenous immunoglobulins; rituximab; eculizumab; calcineurin inhibitors; anticoagulation
Definition of composite endpoint: Renal hematoma; macroscopic hematuria; transfusion during days 1–3 post-TVRB; SOFA score increase ≥1 point from TVRB day to day +3; hemoglobin decrease ≤ –2 g/dL from TVRB day to day +3
The STOP-ACEi Trial: A multi-centre Randomised Controlled Trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) withdrawal in advanced renal disease.
Year: 2013
Region / City: Leeds, Yorkshire and The Humber
Theme: Clinical trials, Chronic Kidney Disease
Document type: Research study protocol
Organization: University of Birmingham Clinical Trials Unit, Hull and East Yorkshire Hospitals NHS Trust
Author: Prof Sunil Bhandari
Target audience: Healthcare professionals, nephrologists, researchers
Period of validity: 3 years
Approval date: 2013
Change date: N/A
Study reference number: 11/30/07
Ethics committee reference: 13/YH/0394
EudraCT number: 2013-003798-82
Sponsor: Hull and East Yorkshire Hospitals NHS Trust
Funding source: Efficacy and Mechanism Evaluation (EME) programme, National Institute for Health Research (NIHR), Medical Research Council (MRC)
Note: Contextual description
Identification of Cell-cell Communications by Single-cell RNA Sequencing in End Stage Renal Disease Provides New Insights into Immune Cell Heterogeneity
Note: Year
Asian Pacific Association for the Study of the Liver Consensus Recommendations on Hepatocellular Carcinoma-2010APASL Consensus Statements and Management Algorithms for Hepatitis C Virus Infection-2012Asian-Pacific Consensus statement on the management of chronic hepatitis B: A 2012 update-2012Acute-on-chronic liver failure: An Update on Consensus Recommendations of the Asian Pacific Association for the Study of the Liver (APASL)-2014ASIAN-PACIFIC CLINICAL PRACTICE GUIDELINES ON THE MANAGEMENT OF HEPATITIS B: A 2015 UPDATE-2015APASL consensus statements and recommendation on treatment of hepatitis C-2016APASL consensus statements and recommendations for hepatitis C prevention, epidemiology and laboratory testing-2016ASIAN-PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL) CONSENSUS GUIDELINES ON INVASIVE AND NON-INVASIVE ASSESSMENT OF HEPATIC FIBROSIS: A 2016 UPDA-2016Asia-Pacific clinical practice guideline on the management of hepatocellular carcinoma: a 2016 update-2017APASL clinical practice recommendation: How to treat HCV-infected patients with renal impairment?-2018APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation-2019ACUTE-ON-CHRONIC LIVER FAILURE: CONSENSUS RECOMMENDATIONS OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL), AN UPDATE-2019The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseases-2020Asia-Pacific Association for the Study of the Liver Clinical Practice Guidance: The diagnosis and management of patients with autoimmune hepatitis-2021Budd-Chiari Syndrome: Consensus Guidelines of the Asian Pacific Association for the Study of the Liver (APASL)-2021APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy-2021APASL Clinical Practice Guidance: The diagnosis and management of patients with primary biliary cholangitis-2021APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients-2021Asian Pacific Association for the Study of Liver (APASL) Guidelines: Hepatitis B Virus in Pregnancy-2021Drug-Induced Liver Injury: Asia Pacific Association of Study of Liver Consensus Guidelines-2021Asian Pacific Association for the Study of the Liver Clinical Practice Guidelines on Liver Transplantation-2023Clinical Practice Guidelines on Haemochromatosis: Asian Pacific Association for the Study of the Liver-2023Asia Pacific Association for Study of Liver Guidelines on Management of Ascites in Liver Disease-2023APASL clinical practice guideline on systemic therapy for hepatocellular carcinoma-2024-2024Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management-2024The Asian Pacific Association for the Study of the Liver clinical practice guideline for the diagnosis and management of metabolic dysfunction-associated fatty liver disease-2024APASL CLINICAL PRACTICE GUIDELINES ON THE MANAGEMENT OF ACUTE KIDNEY INJURY IN ACUTE-ON-CHRONIC LIVER FAILURE-2024Acute-on-chronic liver failure (ACLF) - The ‘Kyoto Consensus’: Steps from Asia-2024
Year: 2010-2024
Region / city: Asia-Pacific
Subject: Hepatology
Document Type: Clinical Practice Guidelines
Organization / Institution: Asian Pacific Association for the Study of the Liver (APASL)
Author: APASL
Target Audience: Healthcare professionals
Period of validity: 2010-2024
Date of approval: 2010
Date of revisions: 2024
Context: Collection of clinical practice guidelines and consensus statements issued by the Asian Pacific Association for the Study of the Liver on various hepatological conditions, including hepatocellular carcinoma, hepatitis B and C, liver transplantation, and metabolic diseases.
Maryland Next Gen NCLEX Test Bank Project September 1, 2022: End Stage Renal Disease and Dialysis Case Study
Year: 2022
Institution: Towson University
Author: Laura Sessions PhD, MScN, RN, CNE
Topic: End Stage Renal Disease, Dialysis, Peritonitis
Document Type: Case Study
Target Audience: Nursing students, healthcare professionals
Case Study Link: https://umaryland.az1.qualtrics.com/jfe/form/SV_d76sxmjHW6XOqTc
Bow-tie Link: https://umaryland.az1.qualtrics.com/jfe/form/SV_8239FzxAw851hzw
Date of Case: September 1, 2022
Evaluation of vancomycin concentrations in critically ill patients receiving continuous renal replacement therapy: Data from the single-center VALLEY study
Year: 2019
Region / city: Malaysia
Topic: Pharmacokinetics, Vancomycin, Critical Care, Renal Replacement Therapy
Document Type: Research Study
Institution: Universiti Teknologi MARA, University of Malaya, Hospital Tengku Ampuan Afzan
Author: Janattul-Ain Jamal, Helmi Sulaiman, Fariz-Safhan Mohamad-Nor, Norkasihan Ibrahim, Ahmad Fauzi Dali, Mohd-Hafiz Abdul-Aziz
Target Audience: Healthcare professionals, researchers
Period of Effect: Not specified
Approval Date: 2019
Date of Changes: Not specified
General Practitioner Acute Renal Colic Pathway
Year: 2024
Region / city: Norfolk and Norwich University Hospital
Subject: Acute Renal Colic Pathway
Document Type: Clinical Guideline
Organization / Institution: Radiology Department
Author: Consultant Radiologist
Target Audience: General Practitioners
Period of Validity: Until 19th October 2025
Approval Date: 19th October 2024
Date of Changes: Not specified
Date of Review: 19th October 2025
Implementation Date: N/A
Version: 1.0
Date: 05/2024
Reason for Change: To originate document
Reference Number: 23626
Glossary: CT, ED, EIA, GP, SDEC, SpR
Consulted: Consultant Radiologists, Imaging Services Manager, Imaging Support Services Manager, CT Lead Radiographers, Radiology Operation Managers, Urology SpR
Responsibilities: General Practitioner, Radiologist, Urology SpR, Radiographer, Radiology Receptionist, Radiology Bookings team, Emergency Department
Eligibility Criteria: Acute unilateral loin pain, aged 18-80
Context: A clinical guideline for managing acute renal colic cases in General Practitioners and related imaging processes at the Norfolk and Norwich University Hospital.
RNA Nanoparticles as Rubber for Compelling Vessel Extravasation to Enhance Tumor Targeting and for Fast Renal Excretion to Reduce Toxicity
Year: 2023
Region / City: Ohio, USA
Topic: Nanotechnology, RNA Nanoparticles, Cancer Targeting
Document Type: Research Article
Organization / Institution: The Ohio State University, Wexner Medical Center
Author: Hongzhi Wang, Chiran Ghimire, Hui Li, Mario Vieweger, Congcong Xu, Peixuan Guo
Target Audience: Researchers, Scientists, Medical Professionals
Period of Validity: N/A
Approval Date: N/A
Date of Changes: N/A
Note: Context
Diseases of the renal system
Year: 2026
Region / city: Not specified
Topic: Renal system diseases, Urinary tract disorders
Document type: Educational material
Institution: Not specified
Author: Not specified
Target audience: Medical students, healthcare professionals
Period of validity: Not specified
Approval date: Not specified
Date of amendments: Not specified
Topics: Vasculitis Cryoglobulinemia Renal